Meetings/Workshops on Stemm-cell research & therapy in the United States (USA)

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

1.
 
14th Stem Cell Research & Regenerative Medicine Conference
ID
867359
Dates
05 Apr 2017 - 06 Apr 2017
Location
Boston, United States
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
2.
 
Stem Cell Summit 2017
ID
867222
Dates
05 Apr 2017 - 07 Apr 2017
Location
Boston, United States
Abstract
GTCbio is proud to present the Stem Cell Summit 2017, to be held on April 5-7, 2017 in Boston, MA. GTCbio's Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.
Contact
Kristen Starkey;     Phone: [626-256-6405];     Email: infogtcbio@gtcbio.com
Related subject(s)
3.
 
6th Stem Cell Product Development & Commercialization Conference
ID
867305
Dates
06 Apr 2017 - 07 Apr 2017
Location
Boston, United States
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
4.
 
Genome Editing USA Congress 2016
ID
853078
Dates
10 May 2017 - 11 May 2017
Location
Boston, United States
Abstract
Oxford Global is proud to present the Genome Editing USA Congress, on the 10th-11th May 2017 in Boston. Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures. The event will be co-located with our Advances in Transgenic Technology Congress.
Contact
Danielle Dalby;     Phone: [+44 1865 248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
genome editing, genetics, transgenic, therapeutic applications of genome editing
Related subject(s)
5.
 
FASEB SRC — Hematologic Malignancies
ID
876910
Dates
23 Jul 2017 - 28 Jul 2017
Location
Saxtons River, VT, United States
Abstract
This SRC focuses on bringing together biochemists, geneticists, molecular biologists and clinicians interested in the pathophysiology of the leukemias and lymphomas, and the development of novel therapies for these diseases. Leukemia and lymphoma has provided a number of key paradigms for molecularly targeted cancer therapy, as illustrated by the remarkable success of all-trans-retinoic acid for the treatment of acute promyelocytic leukemia and tyrosine kinase inhibitor therapy for chronic myelogenous leukemia. New and promising small-molecule compounds and antibodies targeting epigenetic regulators, surface receptors and downstream signaling pathways are currently under development and will be discussed at this meeting. Added to these examples of targeted therapy, immunotherapy, including checkpoint inhibition and modified T cell-based therapies have emerged as important future anti-leukemia/lymphoma treatments.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
cancer, stem cell, hematology, genetics, molecular biology, lymphoma/leukemia
Related subject(s)
6.
 
FASEB SRC — Molecular Mechanisms of Immune Cell Development and Function
ID
876985
Dates
30 Jul 2017 - 04 Aug 2017
Location
Snowmass Village, Colorado, United States
Abstract
This SRC will include a keynote talk by Dan Litmann, a leader in the field, and formal sessions on (1) Early lymphocyte progenitors, (2) Mechanisms that underpin lymphocyte development, (3) Transcriptional regulation of lymphocyte differentiation, (4) Antigen receptor assembly, (5) Molecular and physical mechanisms that promote lymphocyte cell fate, (6) B cell activation and neoplasia, (7) The regulation of the immune responses, 8) Innate immunity and (9) Molecular pathways in innate immunity. These sessions are each anchored by 4 invited speakers with 3 shorter talks chosen from abstracts. The meeting will also include two poster sessions and two workshops consisting of short presentations chosen from submitted abstracts. By highlighting common and contrasting uses of similar mechanisms, the meeting will reveal unexpected synergies between areas of molecular immunology that are traditionally considered distinct. Such discoveries are enhanced by the program’s emphasis on mixing national and international experts with young scientists, including postdoctoral fellows and graduate students, among the presenters in an open atmosphere of scientific exchange. Finally, a large number of oral presentations will be selected from the abstracts.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
immunology, genomics, Molecular Biology, Stem cell
Related subject(s)
7.
 
FASEB SRC — Reversible Acetylation on Health and Disease (HDACs)
ID
871105
Dates
06 Aug 2017 - 11 Aug 2017
Location
Big Sky, Montana, United States
Abstract
Over the past few years, the “epigenetic” regulation of the genome has become increasingly important to understanding both the etiology and fundamental mechanisms of aging and age-related diseases. Key to epigenetic regulation are two classes of lysine-modifying enzymes, the histone deacetylases (sirtuins and HDACs) and the histone acetyltransferases (HATs). Both classes of enzyme are critical for maintaining youthful gene expression patterns, cell cycle progression, DNA repair, stem cells, mitochondria, cell fate, differentiation, cognition, energy utilization, and the pathogenesis of most age-related diseases. Alterations in sirtuin and HDAC function have been linked to neurodegenerative disorders, muscle wasting, cardiac hypertrophy, cancer, HIV infection, and more generally the process of aging. Several HDAC inhibitors have been approved by FDA to treat various cancers. Small molecule modulators of sirtuins are currently in clinical trials for the treatment of cancers, neuromuscular disorders, inflammatory and metabolic disorders. With particular relevance to aging, the sirtuins, a subclass of HDAC, were first identified in yeast genetic studies as regulators of lifespan and the health benefits of dietary restriction. Activation or overexpression of sirtuins have been shown to protect mice and primates from diseases of aging, and extend mean and maximum lifespan of mice. Therefore, a thorough understanding of sirtuins and HDACs is required, not merely for understanding the regulation of chromatin structure, gene regulation and protein function, but also because these enzymes are intimately involved in normal and abnormal cellular processes that greatly impact human health. Although targeting HATs for therapeutic purposes has been relatively slow compared to targeting deacetylases, exciting new progress has also been made in recent years. Importantly, targeting the bromodomains present in many HATs has attracted a lot of attention lately.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
aging, stem cell, cancer, differentiation, structural biology
Related subject(s)

View all listed conferences in the United States (USA).

7th annual conference on Biobanking, taking place on 14th & 15th June 2017 in Central London, UK

Good to know...

You can advertise your event or services in this space.

Last updated: 11 February 2017